Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,949.0
-24.5 (-0.82%)

 

  • STI Straits Times Index
    2,949.0
    -24.5 (-0.82%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,577.8
    -3.8 (-0.24%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,980.2
    -1,094.0 (-3.64%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,509.1
    -76.0 (-2.12%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    -
    -
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,241.8
    -47.8 (-0.76%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,281.1M
  • Value: 2,309.6M
  • Rise: 109
  • Fall: 262
  • Unch: 403

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
CWX Global0.007+0.002
Thomson Medical0.119-
Oceanus^0.071-0.004
Jiutian Chemical0.089-0.006
SPH1.400+0.120
Secura0.102-0.001
YZJ Shipbldg SGD1.070+0.010
Sembcorp Marine0.153-0.002
Anchor Resources0.015-
ThaiBev0.735-

World Indices

World Indices
Name Last Change
Nasdaq 13,119.4 -478.5
HSI 28,980.2 -1094.0
HSCEI 11,247.2 -470.2
Jakarta 6,241.8 -47.9
Nikkei 225 0.0
SSE Comp 3,509.1 -76.0
Shanghai A 3,678.3 -79.7
Shanghai B 243.4 -2.6
KOSPI 3,012.9 -86.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

NOVABAY PHARMACEUTICALS INC NOVABAY PHARMACEUTICALS
Updated on 25 Feb 2021 (End of trading day)
Last (USD): 1.120 Change: -0.120 High: 1.230 Remarks: -
Change (%): -9.68 Low: 1.100
Open 1.230 Yesterday's Close 1.2400000000000002
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 4,380,134 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.68502 Trailing EPS (USD) e -0.83422 NAV (USD) b 0.9068
PE a - Trailing PE f - Price / NAV b 1.2351
Dividend (USD) d - Cash In Hand (USD) g 0.8762 Issued & Paid-up Shares c 41,782,600
Dividend Yield (%) d - Price / Cash In Hand g 1.278 Treasury Shares h -
Market Cap (M) 17.146 Enterprise Value (M) 4.434
Piotroski F Score 0 Exchange Code NBY Par Value ( $ ) n.a.
52 Weeks Volatility (%) 124.57 Free Float (%) 74.8
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 13 Nov 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference NOVABAY PHARMACEUTICALS INC NYSE American 17.146 - - 1.2351 -
Industry Biotechnology NYSE American 175.500 - - 4.3409 -
Local Peer ACTINIUM PHARMACEUTICALS INC NYSE American 629.765 - - 13.8630 -
Local Peer 22ND CENTURY GROUP INC NYSE American 350.412 - - 7.0035 -
Local Peer LINEAGE CELL THERAPEUTICS INC NYSE American 343.479 - - 3.7634 -
Local Peer NANOVIRICIDES INC NYSE American 260.487 - - 9.3885 -
Local Peer IBIO INC NYSE American 171.715 - - 1.5998 -
Local Peer CEL-SCI CORP NYSE American 171.409 - - 5.9442 -
Local Peer PALATIN TECHNOLOGIES INC NYSE American 125.298 - - 1.8473 -
Local Peer MATINAS BIOPHARMA HOLDINGS INC NYSE American 118.644 - - 1.8468 -
Local Peer ARMATA PHARMACEUTICALS INC NYSE American 118.487 - - 4.8129 -
Local Peer AIM IMMUNOTECH INC NYSE American 95.613 - - 1.5836 -
Local Peer SYNTHETIC BIOLOGICS INC NYSE American 88.503 - - -10.2541 -
Local Peer INDIA GLOBALIZATION CAPITAL INC NYSE American 55.335 - - 2.5772 -
Other Local Peers ORAGENICS INC (NYSE American), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American)
Global Peer AMGEN INC NASDAQ 131,407.816 18.090 18.090 13.9662 2.817
Global Peer CSL LTD ASX 119,481.601 38.096 31.394 11.3063 1.118
Global Peer GILEAD SCIENCES INC NASDAQ 78,738.660 640.126 640.152 4.3213 4.332
Global Peer ILLUMINA INC NASDAQ 65,050.974 99.163 99.163 13.8583 -
Global Peer MODERNA INC NASDAQ 58,715.450 - - 21.2753 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 55,366.281 20.418 20.418 6.3736 -
Global Peer WUXI BIO HKEx 404,384.907 351.767 280.841 27.0708 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 48,551.137 13.820 13.820 4.4036 -
Global Peer BIOGEN INC NASDAQ 42,236.679 10.558 10.558 3.9472 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 33,779.645 55.982 55.982 2.8992 -
Other Global Peers BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BEIGENE (HKEx), SEAGEN INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SINO BIOPHARM (HKEx), 10X GENOMICS INC (NASDAQ), INCYTE CORPORATION (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), BIO-TECHNE CORP (NASDAQ), NOVAVAX INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ZAI LAB-SB (HKEx), ABCELLERA BIOLOGICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), BEAM THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), FIBROGEN INC (NASDAQ), Lonza (SGX), JOINN (HKEx), VERACYTE INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), ARVINAS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), GENSCRIPT BIO (HKEx), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), SEER INC (NASDAQ), ALKERMES PLC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), VIELA BIO INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), XENCOR INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), ALLOVIR INC (NASDAQ), 3SBIO (HKEx), DECIPHERA PHARMACEUTICALS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), NUVATION BIO INC (NYSE), ARCUS BIOSCIENCES INC (NYSE), KYMERA THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), JW THERAP-B (HKEx), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), VOR BIOPHARMA INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), JACOBIO-B (HKEx), MYOVANT SCIENCES LTD (NYSE), NGM BIOPHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), BIOATLA INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), SERES THERAPEUTICS (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), SHATTUCK LABS INC (NASDAQ), PRECIGEN INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), VIVA BIOTECH (HKEx), TRANSLATE BIO INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), UNIQURE N.V. (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), NKARTA INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), ALPHAMAB-B (HKEx), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), IMMUNOVANT INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), OCUGEN INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), CYTOKINETICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), PERSONALIS INC (NASDAQ), FRONTAGE (HKEx), HAOHAI BIOTEC (HKEx), BIOXCEL THERAPEUTICS INC (NASDAQ), POLYNOVO LIMITED (ASX), MANNKIND CORPORATION (NASDAQ), VAXCYTE INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), JHBP-B (HKEx), OMEROS CORP (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), MESOBLAST LTD (ASX), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), ASCENTAGE-B (HKEx), COHERUS BIOSCIENCES INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), VANDA PHARMACE INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), INHIBRX INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), CORTEXYME INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), PASSAGE BIO INC (NASDAQ), HUMANIGEN INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), PROTHENA CORP PLC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), CHIMERIX INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), TELIX PHARMACEUTIC (ASX), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), CURIS INC (NASDAQ), VAXART INC (NASDAQ), KINTOR PHARMA-B (HKEx), VBI VACCINES INC CDA (NASDAQ), KADMON HLDGS INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), AGENUS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), MERUS B V (NASDAQ), COMPUGEN (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), IMMATICS N V (NASDAQ), AKOUOS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), ATRECA INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), ARDELYX INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), ALTIMMUNE INC (NASDAQ), GERON CORP (NASDAQ), XBIOTECH INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), SINOMAB BIO-B (HKEx), IVERIC BIO INC (NASDAQ), DPHARMA (Bursa), ALDEYRA THERAPEUTICS (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), ADICET BIO INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), AVROBIO INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), LEE'S PHARM (HKEx), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), ASCLETIS-B (HKEx), OPTHEA LIMITED (ASX), SQZ BIOTECHNOLOGIES CO (NYSE), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), ONCORUS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), SESEN BIO INC (NASDAQ), ATHERSYS INC (NASDAQ), IMMUNOME INC (NASDAQ), BIOVIE INC (NASDAQ), VERASTEM INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), IMUGENE LIMITED (ASX), XOMA CORP (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), ANTEOTECH LIMITED (ASX), FORTE BIOSCIENCES INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), TREVENA INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), ESSEX BIO-TECH (HKEx), PARATEK PHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), NEXTCURE INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), KAMADA LTD (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), MEDICINOVA INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), IMV INC (NASDAQ), CHIASMA INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), EVOGENE LTD (NASDAQ), AXCELLA HEALTH INC (NASDAQ), EQUILLIUM INC (NASDAQ), METACRINE INC (NASDAQ), INMUNE BIO INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), NEXT SCIENCE LTD (ASX), BIONOMICS LTD (ASX), PLURISTEM THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), IMMUTEP LTD (ASX), ENOCHIAN BIOSCIENCES INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), ORGENESIS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), CONTRAFECT CORP (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), ENZO BIOCHEM INC (NYSE), APTEVO THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), ARAVIVE INC (NASDAQ), LONGEVERON INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), SYNLOGIC INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), CAPRICOR THERAPEUTICS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), INFLARX N V (NASDAQ), RECRO PHARMA INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), ADVAXIS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), SAVARA INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), UNI-BIO GROUP (HKEx), WINDTREE THERAPEUTICS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), LEAF RESOURCES LTD (ASX), CHIMERIC THERAPEUTICS LTD (ASX), VACCINEX INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), REGENT PACIFIC (HKEx), APPLIED DNA SCIENCES INC (NASDAQ), GENETIC TECHNOLOGIES (ASX), VIRIDIAN THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), BIOCARDIA INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), PLUS THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), MEMPHASYS LTD (ASX), ACORDA THERAPEUTICS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), SOLIGENIX INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), NABRIVA THERAPEUTICS PLC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), CT ENTERPRISE (HKEx), ALIMERA SCIENCES INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), PRECIPIO INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), PATRYS LIMITED (ASX), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), BIOTRON (ASX), CYCLACEL PHARMACEUTICALS INC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), Suntar Eco-City (SGX), AUSTRALIAN PRIMARY HEMP LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), HISTOGEN INC (NASDAQ), CONSTELLATION TECHNOLOGIES LTD (ASX), GEOVAX LABS INC (NASDAQ), ADALTA LTD (ASX), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), RHINOMED LIMITED (ASX), REGENEUS LTD (ASX), SENECA BIOPHARMA INC (NASDAQ), AMPLIA THERAPEUTICS LTD (ASX), XENETIC BIOSCIENCES INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), SENESTECH INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), NANOLLOSE LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), CRYOSITE (ASX), FACTOR THERAPEUTICS LIMITED (ASX), BRIACELL THERAPEUTICS CORP (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.150
-11.81 %
10 Days --0.070
-5.88 %
20 Days -+0.230
+25.84 %
Medium Term Return 3 Months -+0.485
+76.38 %
6 Months -+0.183
+19.53 %
1 Year -+0.545
+94.78 %
Long Term Return 2 Years --0.335
-23.02 %
3 Years --2.080
-65.00 %
5 Years --1.130
-50.22 %
Annualised Return Annualised --
-13.02 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.240 - 1.940 Change From 1 Year Low +0.880 % Change From 1 Year Low (%) +366.67
Change From 1 Year High -0.820 % Change From 1 Year High (%) -42.27
2 Years Range 0.229 - 4.040 Change From 2 Years Low +0.891 % Change From 2 Years Low (%) +389.08
Change From 2 Years High -2.920 % Change From 2 Years High (%) -72.28
5 Years Range 0.229 - 5.290 Change From 5 Years Low +0.891 % Change From 5 Years Low (%) +389.08
Change From 5 Years High -4.170 % Change From 5 Years High (%) -78.83
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing products for the eye care market. Its products include Avenova, NeutroPhase, and CelleRx. The company was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
25 Feb 2021 1.230 1.230 1.100 1.120 4,380,134 -
24 Feb 2021 1.220 1.310 1.210 1.240 3,389,742 -
23 Feb 2021 1.240 1.300 1.130 1.170 8,762,676 -
22 Feb 2021 1.320 1.620 1.230 1.420 24,172,410 -
19 Feb 2021 1.530 1.580 1.220 1.270 12,832,830 -
18 Feb 2021 1.350 1.790 1.340 1.430 33,898,540 -
17 Feb 2021 1.150 1.490 1.070 1.380 19,452,100 -
16 Feb 2021 1.200 1.210 1.160 1.190 2,639,886 -
12 Feb 2021 1.140 1.200 1.140 1.190 2,180,988 -
11 Feb 2021 1.210 1.220 1.140 1.180 3,165,214 -
10 Feb 2021 1.250 1.260 1.070 1.190 5,799,645 -
09 Feb 2021 1.250 1.260 1.130 1.200 6,202,435 -
08 Feb 2021 1.040 1.230 1.030 1.230 12,841,590 -
05 Feb 2021 1.010 1.040 0.931 1.000 3,407,313 -
04 Feb 2021 0.970 1.040 0.960 1.010 4,538,565 -
03 Feb 2021 0.910 0.969 0.903 0.949 2,403,864 -
02 Feb 2021 0.900 0.961 0.900 0.906 2,507,234 -
01 Feb 2021 0.890 0.935 0.872 0.915 2,158,766 -
29 Jan 2021 0.903 0.935 0.850 0.890 4,136,271 -
28 Jan 2021 0.950 0.960 0.860 0.913 3,636,858 -
27 Jan 2021 0.989 1.100 0.945 0.950 5,551,459 -
26 Jan 2021 0.940 1.040 0.922 1.040 6,397,886 -
Summary
Current 2 Weeks
(11 Feb 2021 to 25 Feb 2021)
1.210 1.790 1.070 1.120 114,874,520 -
Previous 2 Weeks
(28 Jan 2021 to 10 Feb 2021)
0.950 1.790 0.860 1.190 47,632,541 -
4 Weeks from
(29 Dec 2020 to 27 Jan 2021)
0.730 1.790 0.680 0.950 92,380,303 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.